Valuation: Kenvue Inc.

Market Cap 34.32B 29.91B 28.3B 25.69B 48.02B 3,292B 48.28B 337B 130B 1,670B 129B 126B 5,353B P/E 2026 *
18.8x
P/E 2027 * 16.4x
Enterprise Value 41.42B 36.09B 34.16B 31.01B 57.95B 3,973B 58.27B 407B 157B 2,015B 156B 152B 6,461B EV / Sales 2026 *
2.66x
EV / Sales 2027 * 2.56x
Free-Float
98.88%
Yield 2026 *
4.72%
Yield 2027 * 4.82%
1 day+0.22%
1 week+0.68%
Current month-5.35%
1 month-6.93%
3 months-3.04%
6 months+0.90%
Current year+3.59%
1 week 17.6
Extreme 17.6
18.2
1 month 17.6
Extreme 17.6
19.56
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+0.22%+0.68%-1.43%-15.79% 34.25B
+0.36%+3.44%-6.64%-3.86% 341B
-0.16%+0.25%-9.34%+0.35% 134B
+0.82%-0.34%+7.67%+19.90% 69.37B
-1.01%-0.14%-24.75%-21.36% 48.05B
-1.82%-4.97%+6.03%-39.72% 34.59B
+1.66%+2.34%+3.30%+23.62% 20.04B
+0.48%+0.46%-18.56%-38.64% 18.79B
+0.23%+0.46%+6.87%+8.77% 18.28B
+1.16%+1.07%-28.99%-12.88% 9.21B
Average +0.17%+0.12%-6.58%-7.96% 72.84B
Weighted average by Cap. +0.05%+1.35%-6.10%-4.18%

Financials

2026 *2027 *
Net sales 15.6B 13.59B 12.86B 11.67B 21.82B 1,496B 21.94B 153B 59.17B 759B 58.57B 57.27B 2,432B 15.97B 13.91B 13.16B 11.95B 22.34B 1,532B 22.46B 157B 60.58B 777B 59.96B 58.64B 2,490B
Net income 1.83B 1.59B 1.51B 1.37B 2.56B 175B 2.57B 17.93B 6.93B 88.89B 6.86B 6.71B 285B 2.1B 1.83B 1.73B 1.57B 2.94B 202B 2.96B 20.63B 7.97B 102B 7.89B 7.72B 328B
Net Debt 7.1B 6.19B 5.85B 5.31B 9.93B 681B 9.99B 69.69B 26.94B 345B 26.66B 26.07B 1,107B 6.53B 5.69B 5.39B 4.89B 9.14B 627B 9.19B 64.12B 24.78B 318B 24.53B 23.99B 1,019B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-09-17 US$17.87 +0.22% 21,893,687
26-09-16 US$17.83 -0.50% 23,064,951
26-09-15 US$17.92 +0.06% 53,825,344
26-09-14 US$17.91 +0.73% 40,652,820
26-09-11 US$17.78 -0.06% 47,161,108
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
17.87USD
Average target price
19.50USD
Spread / Average Target
+9.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!